TRAP-6 (2-6)

CAS No. 141136-84-7

TRAP-6 (2-6)( ——— )

Catalog No. M40463 CAS No. 141136-84-7

FLLRN is a biological active peptide. (PAR1-specific antagonist peptide)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 186 In Stock
10MG 314 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TRAP-6 (2-6)
  • Note
    Research use only, not for human use.
  • Brief Description
    FLLRN is a biological active peptide. (PAR1-specific antagonist peptide)
  • Description
    FLLRN is a biological active peptide. (PAR1-specific antagonist peptide)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    PAR1
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    141136-84-7
  • Formula Weight
    661.81
  • Molecular Formula
    C31H51N9O7
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 100 mg/mL (151.11 mM; ultraphonic; )
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Brequinar

    Brequinar is a potent inhibitor of dihydroorotate dehydrogenase with potent activities against a broad spectrum of viruses.

  • Hepcidin antagonist-...

    Hepcidin antagonist-1 is an iron-modulating antagonist.Hepcidin antagonist-1 can be used to study metabolic disorders such as iron-deficiency diseases and anemia.

  • Examorelin

    Examorelin is an agonist of growth hormone-releasing factor (GHRF), and for the treatment of cardiac diseases.hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment.?